Rolf Peter Kreutz, M.D., FSCAI

Indiana University School of Medicine
Indianapolis, IN
USA

Papers:

Intensifying P2Y12 Inhibitor Treatment Does Not Abolish Risk Associated With High-on Treatment Platelet Reactivity After Percutaneous Coronary Intervention
Impact of Routine Platelet Reactivity Testing With VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention